About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Concord Biotech Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
543960
ISIN Demat
INE338H01029
Book Value
174.47
NSE Code
CONCORDBIO
Dividend Yield %
0.78
Market Cap
143381.74
P/E
44.60
EPS
30.73
Face Value
1
BSE
NSE
12-Dec-2025
BSE
NSE
NSE F & O
12-Dec-2025
BSE
NSE
NSE F & O
Last Price
1370.55
Net Change
0.85
% Change
0.06%
Prev.Close
1369.70
Open
1369.70
High
1375.00
Low
1356.70
Volume
2302
Last Price
1369.80
Net Change
-0.4
% Change
-0.03%
Prev.Close
1370.20
Open
1371.00
High
1384.40
Low
1354.60
Volume
72706
Value
3151986
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
1375.00
52-Week High
2451.65
52-Week Low
1334.50
Value
99447289.4
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
1384.40
52-Week High
2451.70
52-Week Low
1334.20
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
23-Jun-24
29-Jun-24
Dividend
1070 %
03-Sep-25
Company News
19-11-2025
Concord Biotech informs ...
15-11-2025
Concord Biotech informs a...
08-11-2025
Concord Biotech informs a...
08-10-2025
Concord Biotech completes...
08-10-2025
Concord Biotech informs a...
21-08-2025
EU-GMP authorities conduc...
08-08-2025
Concord Biotech informs a...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
